Notably, the inability to repair ICLs is a critical feature of Fanconi Anemia (FA), a genetic disorder with bone marrow failure and cancer predisposition, thus the cells deficient in the FA pathways including BRCA1/2 usually exhibit hypersensitivity to cisplatin8. The gene discussed is BRCA1; the disease is Friedreich ataxia.